ClinicalTrials.Veeva

Menu
E

El Camino Health - Clinical Research Department | Mountain View, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ranibizumab
EYE103

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 3 total trials

A Study of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME (BAROLO)

EYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of remigromig (EYE103) in comparison wi...

Active, not recruiting
Diabetic Macular Edema (DME)
Drug: Ranibizumab
Drug: Remigromig

EYE-RES-102 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of remigromig (EYE103) in comparison wi...

Active, not recruiting
Diabetic Macular Edema (DME)
Drug: Remigromig
Drug: Ranibizumab

Trial sponsors

E

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems